Sherman Matthew L - Insider Non-Derivative Transactions at Deciphera Pharmaceuticals, Inc. (DCPH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 16, 2024, Sherman Matthew L's relationship to Deciphera Pharmaceuticals, Inc. (DCPH) is Officer (EVP & Chief Medical Officer), and currently has 108,739 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DCPH insiders.
Data Source: SEC.
Sherman Matthew L - Insider Non-Derivative Transactions of DCPH Common Stock
Sherman Matthew L - Insider Non-Derivative Transactions at DCPH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 17, 2024 | Sell -- (Common Stock) | 2615 | 15.62 | 108739 |
| Feb 16, 2024 | Acquisition -- (Common Stock) | 17275 | 0 | 111354 |
| Jan 17, 2024 | Sell -- (Common Stock) | 2435 | 14.47 | 94079 |
| Dec 14, 2023 | Sell -- (Common Stock) | 2792 | 15.37 | 96514 |
| Dec 13, 2023 | Acquisition -- (Common Stock) | 8244 | 0 | 99306 |
| Oct 31, 2023 | Sell -- (Common Stock) | 2360 | 12.02 | 90628 |
| Oct 29, 2023 | Acquisition -- (Common Stock) | 8244 | 0 | 92988 |
| Oct 3, 2023 | Sell -- (Common Stock) | 2942 | 12.68 | 84744 |
| Jun 17, 2023 | Sell -- (Common Stock) | 1655 | 14.4 | 87686 |
| Feb 17, 2023 | Sell -- (Common Stock) | 971 | 15.1 | 88145 |
| Feb 16, 2023 | Acquisition -- (Common Stock) | 16488 | 0 | 89116 |
| Jan 18, 2023 | Sell -- (Common Stock) | 2403 | 21.24 | 72628 |